OUR TEAM
Leadership
Our Story
ColubrisMX, Inc. is a medical device company that designs and develops next-generation surgical robotic devices that hold unparalleled promise for providing novel surgical treatment.
Our surgical robots are capable of completing minimally
invasive surgeries and endoluminal surgeries.
Led by a Research and Development Team comprising expert engineers and internationally recognized surgeons,
ColubrisMX is located in Houston, Texas, at the heart of the Texas Medical Center,
the largest medical complex of its kind in the world.
Leadership
Kurt Azarbarzin
Chief Executive Officer
Kurt Azarbarzin currently serves as CEO of ColubrisMX, a medical device company developing the worlds most advanced fully-robotic Endoluminal (ELS) and Single-Port (SPS) surgical robotic platforms. He was previously the President and CEO of Verb Surgical, a JV between J&J and Google developing soft tissue surgical robots. In addition to his role with ColubrisMX, he currently serves as Chairman of the Board of Directors at Standard Bariatrics, Inc. and TELA Bio, Inc., and is a member of the Executive Board at the Center for Biomedical Innovation and Technology at Yale University.Prior to joining Verb Surgical, he was the Chief Technology Officer of CONMED Corporation where he led the research and development across all subsidiaries and business units. He was previously Founder and CEO of SurgiQuest, Inc., a medical device company focused on minimally invasive surgery that was acquired for $265 million by CONMED Corporation in November 2015.
Daniel Kim, MD, FAANS, FACS
Founder, Chief Operating Officer and Chief Medical Officer
Dr. Daniel Kim, Professor in the Department of Neurosurgery at The University of Texas Health Science Center at Houston (UTHealth), is the Founder, Chief Operating Officer and Chief Medical Officer of ColubrisMX. Dr. Kim has won numerous awards and honors, authored hundreds of papers, owns over 150 patents and published 20 surgical textbooks. He is a preeminent researcher in peripheral nerve repair through nerve transfer and nerve graft and is also recognized for his work in neurorehabilitation through robotics and cortical stimulation, spinal biomechanics, and innovative neuromodulation treatments for chronic pain. Dr. Kim is adjunct professor of Bioengineering, Electrical Engineering and Computer Science at Rice University.
Dongsuk Shin, PhD
Chief Technology Officer
Dongsuk Shin serves as the Chief Technology Officer, leading the Research and Development team. Dr. Shin holds a PhD in Bioengineering from Rice University and has over 15 years of experiences in medical device development. Dr. Shin is a former Assistant Professor of Neurosurgery at The University of Texas Medical School at Houston and led the engineering team at Microsurgical Robotics Laboratory.
Board of Directors
Dr. Daniel Kim
Neurosurgeon and Professor
Founder, ColubrisMX and XCath
Director, Reconstructive Spinal and Peripheral Nerve Surgery at The University of Texas Medical School at Houston
Adjunct Professor of Bioengineering, Electrical Engineering and Computer Science at Rice University
Neeraj Agrawal
Executive Director
Crescent Group
Chief Financial Officer and Board Member, Crescent Group
Executive Board Member and Investment Committee Member, Crescent Enterprises
Executive Board Member and Chair of Investment Committee, Gulftainer Group
Cary McNair
Chairman and CEO McNair Interests
Board Member GlySens Inc and Invectys SA
Former Development Board UTH Science Center and Director Xeris Pharmaceuticals and Goodwill Industries of Houston.
MBA - Southern
Methodist University
Eduardo Fonseca
Investment Director Crescent
Enterprises
Board Member HomeWork Mx
Former Ambassador of Panama to the United Arab Emirates and Saudi Arabia.
MBA - INSEAD
Investors
Crescent Enterprises is a multinational company headquartered in the United Arab Emirates (UAE) that works across numerous sectors, including ports and logistics, power and engineering, and food and beverages
and in verticals such as private equity, venture capital, and business incubation. Their business interests span 33 subsidiaries, affiliates, and investments in 15 countries. Together with their subsidiaries, they employ over 3,000 people.
Crescent Enterprises is a well known investor in US technology, healthcare and other specialized sectors. Gulftainer, one of Crescent Enterprise’s subsidiaries, manages the US ports of Wilmington and Cape Canaveral.
They are a subsidiary of the Crescent Group, founded over 48 years. Crescent Group's other subsidiary, Crescent Petroleum, is the first and largest privately owned indigenous upstream oil and gas company in the Middle East.
McNair Interests is a private investment and management company headquartered in Houston, Texas.
They focus on transformative real estate projects, breakthrough medical discoveries and disciplined investments have enabled them to build a valuable and diversified company.
They consider every opportunity for its ability to drive innovation while generating value and creating a lasting, positive impact on the community.
McNair Medical, one of their 3 business units, believes in harnessing the power of science to transform the future. They bring a uniquely thoughtful approach to accelerating medicine, improving outcomes and finding cures. McNair Medical ambitiously supports the development of scientific and entrepreneurial solutions for those who suffer from chronic disease.